Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2026-03-01 @ 10:04 AM
Study NCT ID:
NCT03639194
Status:
COMPLETED
Last Update Posted:
2024-02-09
First Post:
2018-08-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of ABBV-011 Alone and in Combination With Budigalimab (ABBV-181) in Participants With Relapsed or Refractory Small Cell Lung Cancer
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-10-24
Start Date Type:
ACTUAL
Primary Completion Date:
2024-01-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-01-25
Completion Date Type:
ACTUAL
First Submit Date:
2018-08-17
First Submit QC Date:
None
Study First Post Date:
2018-08-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-08
Last Update Post Date:
2024-02-09
Last Update Post Date Type:
ACTUAL